The US FDA has stepped up its research on prescription drug advertising. In one week last month, the agency announced four new studies that range from a focus on non-Internet users to disclosures in oncology drug promotions directed to healthcare providers.
The first study, announced in the Federal Register June 12, is looking at ways to modify Rx drug broadcast ads to assure those who do not routinely use the Internet get access to full information about a product's major side effects and contraindications
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?